Prometheus Laboratories recalls
Prometheus Laboratories appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2014-11-26.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 2 |
|---|---|
| Published | 2012-08-29 to 2014-11-26 |
| By agency | FDA Drug (2) |
| By classification | Class II (2) |
| By status | terminated (2) |
| Distribution named in notices | US |
Recalls
- Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b) 250-count bottle (NDC 49884-922-04), RX only, Manufactured by S…
FDA Drug · Class II · 2014-11-26 · Prometheus Laboratories
Reason: Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing. - Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC…
FDA Drug · Class II · 2012-08-29 · Prometheus Laboratories
Reason: Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.